Nicotine Replacement Therapy in the Intensive Care Unit

The test product is a transdermal nicotine patch. The dosage of the test product depends on the amount of cigarettes used by a specific patient (21 or more or less than 21) delivering 21 or 14 mg nicotine/24 hrs. During the study period of thirty (30) days a patch will be applicated daily.

During the study period of thirty (30) days, the control product will be applicated daily.